CNTX: Context Therapeutics Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | MPM BioImpact LLC | 1.40% | SEC | |
| 2026-08-12 | Fell below 5% | Blue Owl Capital Holdings LP | 3.19% | SEC | |
| 2026-07-31 | Fell below 5% | Octagon Capital Advisors LP | 3.30% | SEC | |
| 2026-07-27 | New 13G stake | BlackRock, Inc. | 6.70% | SEC |
Institutional ownership (Q2 2026)
79 institutions reported holding $34.09M of Context Therapeutics Inc. on Form 13F (60 the quarter before). 36 opened a new position and 16 sold out. Shares held by institutions: -15%.
| Largest holders | Shares | Value |
|---|---|---|
| Nextech Invest Ltd. | 7,419,355 | $4.11M |
| Deep Track Capital, LP | 7,419,355 | $4.11M |
| Soleus Capital Management, L.P. | 7,063,141 | $3.91M |
| BlackRock, Inc. | 6,169,250 | $3.42M |
| Avidity Partners Management LP | 4,998,267 | $2.77M |
| FRANKLIN RESOURCES INC | 3,803,338 | $2.11M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,432,052 | $1.90M |
| Octagon Capital Advisors LP | 3,050,000 | $1.69M |
| Blue Owl Capital Holdings LP | 2,934,015 | $1.63M |
| TCG Crossover Management, LLC | 2,682,696 | $1.49M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.